Insurance for Shoulder HA Injections

---

Why Coverage Is Complicated

Every HA product on the market (Synvisc-One, Durolane, Euflexxa, Hyalgan, Supartz, Monovisc, Gel-One) is FDA-approved specifically for knee osteoarthritis. When a doctor injects HA into a shoulder, hip, or any other joint, that is considered off-label use.

Off-label does not mean unsafe or inappropriate. Doctors prescribe medications off-label routinely when evidence supports it. But insurance companies use the FDA-approved indication as their baseline for coverage decisions.

The result: coverage for shoulder HA injections requires navigating individual insurer policies, local coverage determinations, and often an appeals process.

---

Coverage by Insurer Type

Original Medicare (Part B)

Status: Varies by region

Medicare does not have a national coverage determination specifically addressing shoulder HA injections. Coverage depends on your local Medicare Administrative Contractor (MAC).

• Some MACs cover it with proper documentation of medical necessity
• Some MACs deny it based on the knee-only FDA indication
• Prior authorization may be required
• Appeal rights exist and are often successful with supporting evidence

Your action step: Ask your provider’s billing department which MAC handles your claims and what their specific policy says about shoulder viscosupplementation.

Medicare Advantage Plans

Status: Plan-specific

Medicare Advantage (Part C) plans set their own coverage policies that must meet or exceed Original Medicare minimums. Some MA plans are more generous with off-label coverage, while others are stricter.

• Check your plan’s formulary and medical policy documents
• Call the number on the back of your card and ask specifically about shoulder HA injections
• Request any coverage determination in writing

Blue Cross Blue Shield (BCBS)

Status: Varies by state and plan

BCBS is a network of independent companies, so coverage varies significantly.

• Some BCBS plans have medical policies that cover viscosupplementation for OA in any weight-bearing or synovial joint (which includes the shoulder)
• Others limit coverage to knee OA only
• Anthem BCBS, CareFirst, and other large affiliates have published policies that you can often find on their provider websites

UnitedHealthcare (UHC)

Status: Generally restrictive for shoulder

UnitedHealthcare’s medical policy has historically limited viscosupplementation coverage to knee OA. Shoulder HA may be denied as “not medically necessary” under their standard policy. Appeals with strong documentation may succeed in some cases.

Aetna

Status: Restrictive

Aetna’s clinical policy bulletin on viscosupplementation considers HA injections for non-knee joints (including shoulder) experimental or investigational. Coverage is unlikely under standard policies.

Cigna

Status: Varies by plan

Cigna evaluates coverage based on medical necessity criteria that can include off-label uses when supported by peer-reviewed evidence. Outcomes depend on your specific plan and the documentation submitted.

Humana

Status: Generally follows Medicare guidelines

Humana Medicare Advantage plans often mirror Original Medicare coverage determinations. Coverage depends on the applicable MAC’s local policy.

---

How to Get Coverage Approved

Even with restrictive policies, documentation and persistence can result in coverage approval.

Step 1: Build Your Medical Record

Before requesting HA injections, ensure your medical records document:

• Confirmed shoulder OA with imaging (X-rays showing joint space narrowing)
• Failed conservative treatments: At least 4-6 weeks of physical therapy, NSAIDs or acetaminophen trial, activity modification
• Cortisone injection history: If cortisone provided temporary relief but wore off quickly, this supports the case for HA
• Functional limitations: Specific documentation of activities you cannot perform
• Pain severity: Consistent pain ratings and how they affect daily life

Step 2: Prior Authorization

Most plans require prior authorization for HA injections.

Your provider’s office submits:

• Diagnosis codes (ICD-10 for shoulder OA)
• Procedure codes (CPT for viscosupplementation)
• Supporting documentation (imaging, treatment history, letter of medical necessity)

Allow 5-15 business days for processing.

Step 3: Letter of Medical Necessity

A strong letter from your doctor should include:

• Your specific diagnosis and severity
• Complete list of treatments tried and their outcomes
• Explanation of why HA is appropriate for your situation
• Reference to published clinical evidence supporting shoulder HA
• Statement that the patient has not responded adequately to covered alternatives

Step 4: Appeal If Denied

Appeal tips:

• Respond within the appeal deadline (usually 60-180 days depending on the insurer)
• Include all supporting documentation
• Reference specific clinical studies supporting shoulder HA
• Consider requesting a peer-to-peer review (your doctor speaks directly with the insurer’s medical director)
• Escalate to external review if internal appeals are exhausted

---

If Insurance Does Not Cover It

Out-of-Pocket Options

• Cash-pay pricing: Ask for a self-pay discount (typically 20-40% off billed charges)
• Payment plans: Many providers offer installment payments
• Medical financing: CareCredit and similar programs offer interest-free periods
• Manufacturer programs: Some HA companies offer savings cards or copay assistance (primarily for insured patients)

Cost vs. Value Calculation

Consider the math:

• One HA treatment series: $500-$1,500 out of pocket
• Relief duration: 3-6 months
• Annual cost if repeated twice: $1,000-$3,000
• Shoulder replacement surgery: $25,000-$60,000 (even with insurance, deductible and coinsurance may total $3,000-$8,000)

If HA injections delay surgery by even 2-3 years, the cumulative injection cost is often less than the out-of-pocket cost of surgery.

---

Frequently Asked Questions

Why does insurance cover knee HA but not shoulder HA?

Insurance coverage follows FDA-approved indications as a baseline. HA products are FDA-approved for knee OA specifically. Shoulder use, while supported by clinical evidence, is off-label. Insurers have more discretion to deny off-label uses, even when evidence supports them.

Can my doctor help me get coverage?

Yes. Your doctor can write a detailed letter of medical necessity, participate in peer-to-peer reviews with the insurance company’s medical director, and provide documentation of failed treatments. A proactive provider makes a significant difference in coverage outcomes.

What if I have two insurance plans?

If you have dual coverage (e.g., Medicare plus a Medigap supplement, or two employer plans), coordinate benefits through both plans. The primary plan processes the claim first, and the secondary plan may cover remaining costs. Coverage for shoulder HA still depends on each plan’s individual policy.

How often can I get shoulder HA injections if I pay out of pocket?

Without insurance restrictions, the medical guideline is every 6-12 months as long as the injections are providing benefit. There is no strict medical limit on the number of HA injection series, unlike cortisone.

Are there specific HA brands more likely to be covered for shoulder?

No specific brand has better shoulder coverage than others. All are FDA-approved for knee OA only. However, some plans have preferred HA products on their formulary that may have a simpler approval process. Ask your insurance company which HA products they cover for any joint.

---

Related Resources

• Medicare Shoulder Injection Coverage
• Shoulder Injection Cost Guide
• Shoulder Gel Injections Guide
• Medicare Gel Injections Coverage 2026
• BCBS Coverage Changes 2026